DGX
Quest Diagnostics Incorporated
Quest Diagnostics (DGX) is a clinical laboratory services provider with $703M in federal contracts and 8 congressional traders, including Rep. Michael McCaul (R-TX) with $984K in buys.
Govt Dependence
65/100
Regulatory Density
80/100
Lobbying Intensity
40/100
Political Signal
BULLISH
BusinessWhat DGX does
Quest Diagnostics provides diagnostic testing, information, and services to patients, clinicians, hospitals, employers, and health plans. Revenue lines include clinical testing, anatomic pathology, and esoteric testing, with significant federal contract revenue from agencies like the Department of Defense and Department of Health and Human Services.
12 months past · 3 months futureDGX activity timeline
Congress
buy
sell
Insider · Form 4
open-market buy
Hedge fund · 13F
opened
+ added
− trimmed
closed
holds
Bills
past action (this ticker)
upcoming markup (sector)
★ carveout (this ticker)
240 trading days ·
3 congressional trades shown
·
0 insider buys
·
8 13F filings
·
3 past bill actions
·
16 upcoming markups
Executive Branch ConflictsDGX held by Trump-administration officials
1 cabinet/senior official reported DGX positions in OGE Form 278 disclosures across 1 filings.
Lifetime Government AwardsDGX federal contracts by year
$703M
total awarded · 2013–2026
498
contracts on file
2022
peak year ($121M)
Top contracts by award amount
$43.8M
Department of Veterans Affairs
2016-07-01
IGF::OT::IGF MEDICAL LAB SERVICES
$27.1M
Department of Health and Human Serv
2022-05-16
COVID 19 GENOMIC SEQUENCING
$22.8M
Department of Health and Human Serv
2020-11-13
SEROLOGY TESTING SERVICES
$10.4M
Department of Health and Human Serv
2020-04-04
COVID-19 SELF-SWAB AND POINT-OF-CARE TESTING PUBLIC-PRIVATE PARTNERSHI
$9.6M
Department of Veterans Affairs
2021-10-05
VISN 6 REFERENCE LABORATORY TESTING AND COURIER SERVICES
14 years · 498 contracts
Smart Money · 13F HoldingsHedge funds holding DGX
$608.2M
Total DGX held by tracked 13F funds
35
Funds with DGX positions
+35
Funds opened this quarter
Citadel Advisors
$160M
opened
2024-06-30
Citadel Advisors
$116M
opened
2024-09-30
D.E. Shaw & Co.
$57M
opened
2 overlap
2025-12-31
Citadel Advisors
$44M
opened
2 overlap
2025-12-31
Bridgewater Associates
$26M
opened
2024-03-31
Citadel Advisors
$25M
opened
2025-09-30
Citadel Advisors
$23M
opened
2025-03-31
Bridgewater Associates
$20M
opened
2024-06-30
27 more 13F positions tracked · quarterly delta charts available in member dashboard
Politicians Trading DGXMembers of Congress with recent DGX positions
4 politicians traded DGX across 12 disclosed transactions totaling $96K (last 730 days).
Greed score = composite of trade frequency, volume & recency across the politician's entire history (not just DGX). 0-30 LOW · 30-60 MID · 60+ HIGH.
Congressional TradesWho in Congress is trading DGX
2026-01-29
Ro Khanna
Purchase
$1,001 - $15,000
2025-07-24
Julia Letlow
Sale
$1,001 - $15,000
173d late
2025-04-28
Julia Letlow
Purchase
$1,001 - $15,000
260d late
2025-11-03
Julie Johnson
Sale
$1,001 - $15,000
2025-03-10
Carol D. Miller
Sale
$1,001 - $15,000
2025-03-10
Carol D. Miller
sale
$1,001 - $15,000
2025-01-17
Ro Khanna
Purchase
$1,001 - $15,000
2025-01-17
Ro Khanna
purchase
$1,001 - $15,000
2024-11-15
Ro Khanna
Purchase
$1,001 - $15,000
2024-11-12
Ro Khanna
Purchase
$1,001 - $15,000
2024-11-12
Ro Khanna
purchase
$1,001 - $15,000
2024-11-15
Ro Khanna
purchase
$1,001 - $15,000
30+ trades on file · most recent 2026-02-06
Corporate Insiders · Form 4What CEOs, CFOs, and directors are doing with their own stock
No Form 4 activity recorded in the last 180 days.
Bills Affecting DGXLive legislation impacting this stock
S.827 · 119th
Supporting Rural Veterans Access to Healthcare Services Act
HR.1860 · 119th
Women Veterans Cancer Care Coordination Act
HR.2068 · 119th
Veterans Patient Advocacy Act
HR.2020 · 119th
New Mexico Rural Veteran Health Care Access Act
S.999 · 119th
Public Health Improvement Act
HR.2062 · 119th
To amend the Internal Revenue Code of 1986 to treat membership in a health care sharing ministry as a medical expense, and for oth
HR.2085 · 119th
Mental Health Research Accelerator Act of 2025
HR.2045 · 119th
Medicare Dental, Vision, and Hearing Benefit Act of 2025
HR.2048 · 119th
Metastatic Breast Cancer Access to Care Act
SJRES.36 · 119th
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted b
Political ProfileWhere DGX sits in Washington
[object Object]
STRUCTURAL: 8 congressional traders with committee alignment (e.g., Rep. Letlow chairs HHS Appropriations subcommittee), $160K lobbying on Medicare payment delays, $703M federal contracts across 7 agencies. EVIDENTIARY: Rep. McCaul's $984K in buys, Rep. Khanna's $200K buys, and Trump executive branch holding. Net: Strong structural support with evidentiary buys, though no corporate insider buys.
Regulatory ExposureThreats & opportunities
Regulatory threats
-
Medicare payment cuts for laboratory servicesCenters for Medicare & Medicaid Services (CMS)"get_political_influence.lobbying_patterns[0].lobbying_events show lobbying on 'delay to certain cuts to laboratory payments covered by Medicare'"
-
FDA regulation of laboratory developed tests (LDTs)Food and Drug Administration (FDA)"get_political_influence.lobbying_filings[0].specific_issues includes 'Rules and regulations related to FDA's treatment of certain laboratory developed tests'"
Regulatory opportunities
-
Funding for syphilis crisis testing and PFAS testing programsDepartment of Health and Human Services"get_political_influence.lobbying_filings[0].specific_issues includes 'Issues related to combatting the syphilis crisis... and testing for PFAS'"
-
Support for Cancer Moonshot initiative testingNational Institutes of Health"get_political_influence.lobbying_filings[0].specific_issues includes 'Issues related to the Cancer Moonshot initiative'"
Capitol Hill AlliesChampions & critics
Congressional champions
Congressional critics
- No specific congressional critics identified.
LobbyingWho's hired to advocate for DGX
RED+BLUE STRATEGIES · $160K healthcare
Member intelligence layer
Live signals + predictions for DGX — for Founders
The free page above gives you the public record. Members see the real-time intelligence layer on top of it:
- Live 7-layer signal scores when Congress trades DGX
- Bill Pass Index v2 odds for every bill on the watch list
- Iron Triangle alerts (committee × donor × trade)
- SEC Form 4 cluster detection (CEO + CFO + director buys)
- Whale-Opportunity expected-value ranking
- Custom watchlist alerts via email + Discord
Frequently AskedAbout DGX & political exposure
Does Quest Diagnostics Incorporated (DGX) hold federal contracts?
Yes. Quest Diagnostics Incorporated has 498 federal contract awards totaling $702,951,648, primarily from agencies including Department of Defense, Department of Health and Human Services, Department of Homeland Security. See full contract list and amounts on this page.
Which Trump cabinet officials own DGX stock?
1 Trump cabinet members or senior White House staff have disclosed holdings in DGX on their OGE 278 financial disclosures, including Donald J. Trump. See the Cabinet Conflicts panel for details.
Has Congress traded DGX stock?
176 congressional trades by 16 unique members of Congress, most recently on 2026-01-29. See the Congressional Trading panel for politician-by-politician breakdown.
What is DGX political risk profile?
Government dependence: 65/100. Lobbying intensity: 40/100. Political signal: bullish. Donor party split: R 0% / D 0%.
How does GovGreed track DGX political activity?
GovGreed integrates STOCK Act congressional trade disclosures, FEC contributions, OGE executive-branch disclosures, USASpending federal contracts, Senate LDA lobbying filings, and SEC Form 4 corporate insider trades into a single queryable graph. DGX data is updated daily from these official federal sources.